{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:38:11Z","timestamp":1740123491115,"version":"3.37.3"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11011-022-01057-7","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T09:02:51Z","timestamp":1660035771000},"page":"2687-2697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peroxisome proliferator-activated receptor-\u03b3 doesn\u2019t modify altered electrophysiological properties of the CA1 pyramidal neurons in a rat model of hepatic cirrhosis"],"prefix":"10.1007","volume":"37","author":[{"given":"Mahshid","family":"Tahamtan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraj","family":"Aghaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Pooladvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2007-3584","authenticated-orcid":false,"given":"Moazamehosadat","family":"Razavinasab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"1057_CR1","doi-asserted-by":"publisher","first-page":"F600","DOI":"10.1152\/ajprenal.00289.2005","volume":"290","author":"R Agarwal","year":"2006","unstructured":"Agarwal R (2006) Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy. Am J Physiology-Renal Physiol 290:F600\u2013F605","journal-title":"Am J Physiology-Renal Physiol"},{"key":"1057_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pbb.2014.03.002","volume":"120","author":"I Aghaei","year":"2014","unstructured":"Aghaei I, Shabani M, Doustar N, Nazeri M, Dehpour A (2014) Peroxisome proliferator-activated receptor-\u03b3 activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis. Pharmacol Biochem Behav 120:133\u2013139","journal-title":"Pharmacol Biochem Behav"},{"key":"1057_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11011-014-9600-x","volume":"30","author":"I Aghaei","year":"2015","unstructured":"Aghaei I, Nazeri M, Shabani M, Mossavinasab M, Mirhosseini FK, Nayebpour M, Dalili A (2015) Erythropoietin ameliorates the motor and cognitive function impairments in a rat model of hepatic cirrhosis. Metab Brain Dis 30:197\u2013204","journal-title":"Metab Brain Dis"},{"key":"1057_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainresbull.2015.12.002","volume":"121","author":"I Aghaei","year":"2016","unstructured":"Aghaei I, Hajali V, Dehpour A, Haghani M, Sheibani V, Shabani M (2016) Alterations in the intrinsic electrophysiological properties of Purkinje neurons in a rat model of hepatic encephalopathy: Relative preventing effect of PPAR\u03b3 agonist. Brain Res Bull 121:16\u201325","journal-title":"Brain Res Bull"},{"key":"1057_CR5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jocn.2018.11.004","volume":"59","author":"I Aghaei","year":"2019","unstructured":"Aghaei I, Hajali V, Haghani M, Vaziri Z, Moosazadeh M, Shabani M (2019) Peroxisome proliferator-activated receptor-\u03b3 activation attenuates harmaline-induced cognitive impairments in rats. J Clin Neurosci 59:276\u2013283","journal-title":"J Clin Neurosci"},{"key":"1057_CR6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1006\/exnr.1999.7299","volume":"161","author":"M Aguilar","year":"2000","unstructured":"Aguilar M, Mi\u00f1arro J, Felipo V (2000) Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats. Exp Neurol 161:704\u2013713","journal-title":"Exp Neurol"},{"key":"1057_CR7","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s11011-015-9669-x","volume":"30","author":"S Ahmadi","year":"2015","unstructured":"Ahmadi S, Poureidi M, Rostamzadeh J (2015) Hepatic encephalopathy induces site-specific changes in gene expression of GluN1 subunit of NMDA receptor in rat brain. Metab Brain Dis 30:1035\u20131041","journal-title":"Metab Brain Dis"},{"key":"1057_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0006-8993(97)01288-2","volume":"782","author":"N Allert","year":"1998","unstructured":"Allert N, K\u00f6ller H, Siebler M (1998) Ammonia-induced depolarization of cultured rat cortical astrocytes. Brain Res 782:261\u2013270","journal-title":"Brain Res"},{"key":"1057_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.brainresbull.2014.04.004","volume":"104","author":"N Arias","year":"2014","unstructured":"Arias N, Fidalgo C, Vallejo G, Arias JL (2014) Brain network function during shifts in learning strategies in portal hypertension animals. Brain Res Bull 104:52\u201359","journal-title":"Brain Res Bull"},{"key":"1057_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbr.2010.07.033","volume":"216","author":"JK Barbiero","year":"2011","unstructured":"Barbiero JK, Santiago RM, Lima MM, Ariza D, Morais LH, Andreatini R, Vital MA (2011) Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson\u2019s disease. Behav Brain Res 216:186\u2013192","journal-title":"Behav Brain Res"},{"key":"1057_CR11","doi-asserted-by":"publisher","first-page":"113234","DOI":"10.1016\/j.expneurol.2020.113234","volume":"327","author":"JK Blackburn","year":"2020","unstructured":"Blackburn JK, Curry DW, Thomsen AN, Roth RH, Elsworth JD (2020) Pioglitazone activates paraoxonase-2 in the brain: a novel neuroprotective mechanism. Exp Neurol 327:113234","journal-title":"Exp Neurol"},{"key":"1057_CR12","doi-asserted-by":"publisher","first-page":"105222","DOI":"10.1016\/j.neuint.2021.105222","volume":"152","author":"JK Blackburn","year":"2022","unstructured":"Blackburn JK, Jamwal S, Wang W, Elsworth JD (2022) Pioglitazone transiently stimulates paraoxonase-2 expression in male nonhuman primate brain: Implications for sex-specific therapeutics in neurodegenerative disorders. Neurochem Int 152:105222","journal-title":"Neurochem Int"},{"key":"1057_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/361031a0","volume":"361","author":"TV Bliss","year":"1993","unstructured":"Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31\u201339","journal-title":"Nature"},{"key":"1057_CR14","doi-asserted-by":"crossref","unstructured":"Bonato JM, Bassani TB, Milani H, Vital MABF (2018) & R. M. W. de Oliveira Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson\u2019s disease in rats. Experimental neurology, 300, 188\u2013200","DOI":"10.1016\/j.expneurol.2017.11.009"},{"key":"1057_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1042\/BST0341341","volume":"34","author":"R Bordet","year":"2006","unstructured":"Bordet R, Ouk T, Petrault O, Gele P, Gautier S, Laprais M, Deplanque D, Duriez P, Staels B, Fruchart J (2006) PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans 34:1341\u20131346","journal-title":"Biochem Soc Trans"},{"key":"1057_CR16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1478-3231.2009.02034.x","volume":"29","author":"RF Butterworth","year":"2009","unstructured":"Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J, Blei AT (2009) Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 29:783\u2013788 o. E. M. o. HE]","journal-title":"Liver Int"},{"key":"1057_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-018-0241-5","volume":"9","author":"L Capano","year":"2018","unstructured":"Capano L, Dupuis A, Brian J, Mankad D, Genore L, Hastie Adams R, Smile S, Lui T, Odrobina D, Foster JA (2018) A pilot dose finding study of pioglitazone in autistic children. Mol autism 9:1\u201314","journal-title":"Mol autism"},{"key":"1057_CR18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jhep.2006.06.019","volume":"45","author":"O Cauli","year":"2006","unstructured":"Cauli O, Llansola M, Erceg S, Felipo V (2006) Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra. J Hepatol 45:654\u2013661","journal-title":"J Hepatol"},{"key":"1057_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/hep.21734","volume":"46","author":"O Cauli","year":"2007","unstructured":"Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V (2007) Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 46:514\u2013519","journal-title":"Hepatology"},{"key":"1057_CR20","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1053\/j.gastro.2008.12.057","volume":"136","author":"O Cauli","year":"2009","unstructured":"Cauli O, Mansouri MT, Agusti A, Felipo V (2009) Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex. Gastroenterology 136:1359\u20131367e2","journal-title":"Gastroenterology"},{"key":"1057_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/hep.20617","volume":"41","author":"T \u00c7elik","year":"2005","unstructured":"\u00c7elik T, G\u00f6ren MZ, \u00c7\u0131nar K, G\u00fcrdal H, \u00d6nder FO, Tan A, Terzio\u011flu B, Bozday\u0131 AM, Bozkaya H, Uzunalimo\u011flu \u00d6 (2005) Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat. Hepatology 41:731\u2013737","journal-title":"Hepatology"},{"key":"1057_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bbr.2015.01.042","volume":"286","author":"S Dhanda","year":"2015","unstructured":"Dhanda S, Sandhir R (2015) Role of dopaminergic and serotonergic neurotransmitters in behavioral alterations observed in rodent model of hepatic encephalopathy. Behav Brain Res 286:222\u2013235","journal-title":"Behav Brain Res"},{"key":"1057_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbi.2018.03.002","volume":"70","author":"S Dhanda","year":"2018","unstructured":"Dhanda S, Gupta S, Halder A, Sunkaria A, Sandhir R (2018) Systemic inflammation without gliosis mediates cognitive deficits through impaired BDNF expression in bile duct ligation model of hepatic encephalopathy. Brain Behav Immun 70:214\u2013232","journal-title":"Brain Behav Immun"},{"key":"1057_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.acthis.2013.01.006","volume":"115","author":"O El Hiba","year":"2013","unstructured":"El Hiba O, Gamrani H, Chatoui H, Ahboucha S (2013) Loss of tyrosine hydroxylase expression within the nigro-striato-cortical pathways in the cirrhotic rat: the possible restorative effect of the neurosteroid dehydroepiandrosterone sulfate. Acta Histochem 115:637\u2013645","journal-title":"Acta Histochem"},{"key":"1057_CR25","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1471-4159.2008.05495.x","volume":"106","author":"N El-Mlili","year":"2008","unstructured":"El-Mlili N, Rodrigo R, Naghizadeh B, Cauli O, Felipo V (2008) Chronic hyperammonemia reduces the activity of neuronal nitric oxide synthase in cerebellum by altering its localization and increasing its phosphorylation by calcium\u2010calmodulin kinase II. J Neurochem 106:1440\u20131449","journal-title":"J Neurochem"},{"key":"1057_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1471-4159.2009.06520.x","volume":"112","author":"N ElMlili","year":"2010","unstructured":"ElMlili N, Boix J, Ahabrach H, Rodrigo R, Errami M, Felipo V (2010) Chronic hyperammonemia induces tonic activation of NMDA receptors in cerebellum. J Neurochem 112:1005\u20131014","journal-title":"J Neurochem"},{"key":"1057_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hep.20565","volume":"41","author":"S Erceg","year":"2005","unstructured":"Erceg S, Monfort P, Hern\u00e1ndez-Viadel M, Rodrigo R, Montoliu C, Felipo V (2005) Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology 41:299\u2013306","journal-title":"Hepatology"},{"key":"1057_CR28","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nrn3587","volume":"14,","author":"V Felipo","year":"2013","unstructured":"Felipo V (2013) Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci 14,:851\u2013858","journal-title":"Nat Rev Neurosci"},{"key":"1057_CR29","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1046\/j.1460-9568.1998.00329.x","volume":"10","author":"C Hermenegildo","year":"1998","unstructured":"Hermenegildo C, Montoliu C, Llansola M, Mu\u00f1oz MD, Gaztelu JM, Mi\u00f1ana MD, Felipo V (1998) Chronic hyperammonemia impairs the glutamate\u2013nitric oxide\u2013cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur J Neurosci 10:3201\u20133209","journal-title":"Eur J Neurosci"},{"key":"1057_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/FBP.0b013e3283618a8c","volume":"24","author":"M Javadi-Paydar","year":"2013","unstructured":"Javadi-Paydar M, Ghiassy B, Ebadian S, Rahimi N, Norouzi A, Dehpour AR (2013) Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats. Behav Pharmacol 24:195\u2013206","journal-title":"Behav Pharmacol"},{"key":"1057_CR31","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2741\/2802","volume":"13","author":"R Kapadia","year":"2008","unstructured":"Kapadia R, Yi J-H, Vemuganti R (2008) Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front bioscience: J virtual Libr 13:1813","journal-title":"Front bioscience: J virtual Libr"},{"key":"1057_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/jnr.10501","volume":"71","author":"T Kielian","year":"2003","unstructured":"Kielian T, Drew PD (2003) Effects of peroxisome proliferator-activated receptor\u2010\u03b3 agonists on central nervous system inflammation. J Neurosci Res 71:315\u2013325","journal-title":"J Neurosci Res"},{"key":"1057_CR33","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.bbr.2008.10.010","volume":"197","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kaundal RK, More S, Sharma SS (2009) Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson\u2019s disease. Behav Brain Res 197:398\u2013403","journal-title":"Behav Brain Res"},{"key":"1057_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11011-012-9347-1","volume":"28","author":"R Leke","year":"2013","unstructured":"Leke R, Oliveira DL, Forgiarini LF, Escobar TD, Hammes TO, Meyer FS, Keiding S, Silveira TR, Schousboe A (2013) Impairment of short term memory in rats with hepatic encephalopathy due to bile duct ligation. Metab Brain Dis 28:187\u2013192","journal-title":"Metab Brain Dis"},{"key":"1057_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1665-2681(19)32137-4","volume":"2","author":"J Lizardi-Cervera","year":"2003","unstructured":"Lizardi-Cervera J, Almeda P, Guevara L, Uribe M (2003) Hepatic encephalopathy: a review. Ann Hepatol 2:122\u2013130","journal-title":"Ann Hepatol"},{"key":"1057_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11011-012-9337-3","volume":"28","author":"M Llansola","year":"2013","unstructured":"Llansola M, Montoliu C, Cauli O, Hern\u00e1ndez-Rabaza V, Agust\u00ed A, Cabrera-Pastor A, Gim\u00e9nez-Garz\u00f3 C, Gonz\u00e1lez-Usano A, Felipo V (2013) Chronic hyperammonemia, glutamatergic neurotransmission and neurological alterations. Metab Brain Dis 28:151\u2013154","journal-title":"Metab Brain Dis"},{"key":"1057_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0079-6123(08)61253-4","volume":"83","author":"G Lynch","year":"1990","unstructured":"Lynch G, Kessler M, Arai A, Larson J (1990) Chapter The nature and causes of hippocampal long-term potentiation. Prog Brain Res 83:233\u2013250","journal-title":"Prog Brain Res"},{"key":"1057_CR38","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jhep.2009.04.021","volume":"51","author":"I Magen","year":"2009","unstructured":"Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM (2009) Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol 51:528\u2013534","journal-title":"J Hepatol"},{"key":"1057_CR39","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1460-9568.2004.03539.x","volume":"20","author":"B McKay","year":"2004","unstructured":"McKay B, Turner R (2004) Kv3 K + channels enable burst output in rat cerebellar Purkinje cells. Eur J Neurosci 20:729\u2013739","journal-title":"Eur J Neurosci"},{"key":"1057_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2007.10.019","volume":"188","author":"M M\u00e9ndez","year":"2008","unstructured":"M\u00e9ndez M, M\u00e9ndez-L\u00f3pez M, L\u00f3pez L, Aller M, \u00c1rias J, Cimadevilla JM, \u00c1rias JL (2008) Spatial memory alterations in three models of hepatic encephalopathy. Behav Brain Res 188:32\u201340","journal-title":"Behav Brain Res"},{"key":"1057_CR41","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0306-4522(01)00128-2","volume":"104","author":"P Monfort","year":"2001","unstructured":"Monfort P, Corbal\u00e1n R, Martinez L, L\u00f3pez-Talavera J-C, C\u00f3rdoba J, Felipo V (2001) Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis. Neuroscience 104:1119\u20131125","journal-title":"Neuroscience"},{"key":"1057_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.09.008","volume":"15","author":"P Monfort","year":"2004","unstructured":"Monfort P, Mu\u00f1oz Ma-D, Felipo V (2004) Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G. Neurobiol Dis 15:1\u201310","journal-title":"Neurobiol Dis"},{"key":"1057_CR43","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1471-4159.2005.03236.x","volume":"94","author":"P Monfort","year":"2005","unstructured":"Monfort P, Mu\u00f1oz MD, Felipo V (2005) Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP\u2010dependent\u2010protein kinase and of phosphodiesterase 5. J Neurochem 94:934\u2013942","journal-title":"J Neurochem"},{"key":"1057_CR44","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1460-9568.2007.05444.x","volume":"25","author":"P Monfort","year":"2007","unstructured":"Monfort P, Erceg S, Piedrafita B, Llansola M, Felipo V (2007) Chronic liver failure in rats impairs glutamatergic synaptic transmission and long-term potentiation in hippocampus and learning ability. Eur J Neurosci 25:2103\u20132111","journal-title":"Eur J Neurosci"},{"key":"1057_CR45","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1023\/A:1007547622844","volume":"25","author":"M-D Mu\u00f1oz","year":"2000","unstructured":"Mu\u00f1oz M-D, Monfort P, Gaztelu J-M, Felipo V (2000) Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro. Neurochem Res 25:437\u2013441","journal-title":"Neurochem Res"},{"key":"1057_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.brainresbull.2011.03.011","volume":"85","author":"M Napolitano","year":"2011","unstructured":"Napolitano M, Costa L, Palermo R, Giovenco A, Vacca A, Gulino A (2011) Protective effect of pioglitazone, a PPAR\u03b3 ligand, in a 3 nitropropionic acid model of Huntington\u2019s disease. Brain Res Bull 85:231\u2013237","journal-title":"Brain Res Bull"},{"key":"1057_CR47","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1124\/jpet.106.113472","volume":"320","author":"S-W Park","year":"2007","unstructured":"Park S-W, Yi J-H, Miranpuri G, Satriotomo I, Bowen K, Resnick DK, Vemuganti R (2007) Thiazolidinedione class of peroxisome proliferator-activated receptor \u03b3 agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J Pharmacol Exp Ther 320:1002\u20131012","journal-title":"J Pharmacol Exp Ther"},{"key":"1057_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.expneurol.2017.03.021","volume":"293","author":"SP Patel","year":"2017","unstructured":"Patel SP, Cox DH, Gollihue JL, Bailey WM, Geldenhuys WJ, Gensel JC, Sullivan PG, Rabchevsky AG (2017) Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery. Exp Neurol 293:74\u201382","journal-title":"Exp Neurol"},{"key":"1057_CR49","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1111\/liv.12771","volume":"35","author":"H Pflugrad","year":"2015","unstructured":"Pflugrad H, Bronzlik P, Raab P, Tryc AB, Goldbecker A, Barg-Hock H, Strassburg CP, Ding XQ, Lanfermann H, Weissenborn K (2015) Cerebral white matter lesions in patients with cirrhosis\u2013causative for hepatic encephalopathy or bystanders? Liver Int 35:1816\u20131823","journal-title":"Liver Int"},{"key":"1057_CR50","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1152\/jn.1990.64.2.565","volume":"64","author":"W Raabe","year":"1990","unstructured":"Raabe W (1990) Effects of NH4 + on reflexes in cat spinal cord. J Neurophysiol 64:565\u2013574","journal-title":"J Neurophysiol"},{"key":"1057_CR51","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1177\/0748233714525497","volume":"32","author":"M Razavinasab","year":"2016","unstructured":"Razavinasab M, Moazzami K, Shabani M (2016) Maternal mobile phone exposure alters intrinsic electrophysiological properties of CA1 pyramidal neurons in rat offspring. Toxicol Ind Health 32:968\u2013979","journal-title":"Toxicol Ind Health"},{"key":"1057_CR52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijantimicag.2019.06.020","volume":"54","author":"NQ Ribeiro","year":"2019","unstructured":"Ribeiro NQ, Santos APN, Em\u00eddio ECP, Costa MC, Freitas GJC, Carmo PHF, Silva MF, de Brito CB, de Souza DG (2019) Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis. Int J Antimicrob Agents 54:301\u2013308 & T. A. Paix\u00e3o","journal-title":"Int J Antimicrob Agents"},{"key":"1057_CR53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.nbd.2004.12.001","volume":"19","author":"R Rodrigo","year":"2005","unstructured":"Rodrigo R, Erceg S, Felipo V (2005) Neurons exposed to ammonia reproduce the differential alteration in nitric oxide modulation of guanylate cyclase in the cerebellum and cortex of patients with liver cirrhosis. Neurobiol Dis 19:150\u2013161","journal-title":"Neurobiol Dis"},{"key":"1057_CR54","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1053\/j.gastro.2010.03.040","volume":"139","author":"R Rodrigo","year":"2010","unstructured":"Rodrigo R, Cauli O, Gomez\u2013Pinedo U, Agusti A, Hernandez\u2013Rabaza V, Garcia\u2013Verdugo JM, Felipo V (2010) Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 139:675\u2013684","journal-title":"Gastroenterology"},{"key":"1057_CR55","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","volume":"73","author":"CF Rose","year":"2020","unstructured":"Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, Vilstrup H, Jalan R (2020) Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. J Hepatol 73:1526\u20131547","journal-title":"J Hepatol"},{"key":"1057_CR56","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.expneurol.2010.10.003","volume":"227","author":"A Sauerbeck","year":"2011","unstructured":"Sauerbeck A, Gao J, Readnower R, Liu M, Pauly JR, Bing G, Sullivan PG (2011) Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury. Exp Neurol 227:128\u2013135","journal-title":"Exp Neurol"},{"key":"1057_CR57","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan D, Afdhal NH (2008) Liver cirrhosis. The Lancet 371:838\u2013851","journal-title":"The Lancet"},{"key":"1057_CR58","doi-asserted-by":"publisher","first-page":"e1003980","DOI":"10.1371\/journal.ppat.1003980","volume":"10","author":"L Serghides","year":"2014","unstructured":"Serghides L, McDonald CR, Lu Z, Friedel M, Cui C, Ho KT, Mount HT, Sled JG, Kain KC (2014) PPAR\u03b3 agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria. PLoS Pathog 10:e1003980","journal-title":"PLoS Pathog"},{"key":"1057_CR59","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.brainresbull.2012.02.001","volume":"87","author":"H Shafaroodi","year":"2012","unstructured":"Shafaroodi H, Moezi L, Ghorbani H, Zaeri M, Hassanpour S, Hassanipour M, Dehpour AR (2012) Sub-chronic treatment with pioglitazone exerts anti-convulsant effects in pentylenetetrazole-induced seizures of mice: The role of nitric oxide. Brain Res Bull 87:544\u2013550","journal-title":"Brain Res Bull"},{"key":"1057_CR60","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pupt.2008.11.011","volume":"22","author":"R Sharma","year":"2009","unstructured":"Sharma R, Kaundal RK, Sharma SS (2009) Amelioration of pulmonary dysfunction and neutrophilic inflammation by PPAR\u03b3 agonist in LPS-exposed guinea pigs. Pulm Pharmacol Ther 22:183\u2013189","journal-title":"Pulm Pharmacol Ther"},{"key":"1057_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-8-91","volume":"8","author":"CR Swanson","year":"2011","unstructured":"Swanson CR, Joers V, Bondarenko V, Brunner K, Simmons HA, Ziegler TE, Kemnitz JW, Johnson JA, Emborg ME (2011) The PPAR-\u03b3 agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. J Neuroinflamm 8:1\u201314","journal-title":"J Neuroinflamm"},{"key":"1057_CR62","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0301-0082(92)90008-3","volume":"39","author":"JC Szerb","year":"1992","unstructured":"Szerb JC, Butterworth RF (1992) Effect of ammonium ions on synaptic transmission in the mammalian central nervous system. Prog Neurobiol 39:135\u2013153","journal-title":"Prog Neurobiol"},{"key":"1057_CR63","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s11011-017-9966-7","volume":"32","author":"M Tahamtan","year":"2017","unstructured":"Tahamtan M, Aghaei I, Pooladvand V, Sheibani V, Khaksari M, Shabani M (2017) Characterization of the CA1 pyramidal neurons in rat model of hepatic cirrhosis: insights into their electrophysiological properties. Metab Brain Dis 32:881\u2013889","journal-title":"Metab Brain Dis"},{"key":"1057_CR64","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.brainresbull.2011.05.001","volume":"85","author":"GK Ulusoy","year":"2011","unstructured":"Ulusoy GK, Celik T, Kayir H, G\u00fcrsoy M, Isik AT, Uzbay TI (2011) Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson\u2019s disease. Brain Res Bull 85:380\u2013384","journal-title":"Brain Res Bull"},{"key":"1057_CR65","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1097\/01.aids.0000192076.03443.6d","volume":"19","author":"K Weissenborn","year":"2005","unstructured":"Weissenborn K, Bokemeyer M, Krause J, Ennen J, Ahl B (2005) Neurological and neuropsychiatric syndromes associated with liver disease. Aids 19:S93\u2013S98","journal-title":"Aids"},{"key":"1057_CR66","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jneuroim.2007.09.029","volume":"192","author":"B Xing","year":"2007","unstructured":"Xing B, Liu M, Bing G (2007) Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-\u03baB and JNK activation and suppression of COX-2 activity. J Neuroimmunol 192:89\u201398","journal-title":"J Neuroimmunol"},{"key":"1057_CR67","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1007\/s11064-019-02907-0","volume":"44","author":"A Zakaria","year":"2019","unstructured":"Zakaria A, Rady M, Mahran L, Abou-Aisha K (2019) Pioglitazone attenuates lipopolysaccharide-induced oxidative stress, dopaminergic neuronal loss and neurobehavioral impairment by activating Nrf2\/ARE\/HO-1. Neurochem Res 44:2856\u20132868","journal-title":"Neurochem Res"},{"key":"1057_CR68","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1460-9568.2005.04200.x","volume":"22","author":"Y Zhao","year":"2005","unstructured":"Zhao Y, Patzer A, Gohlke P, Herdegen T, Culman J (2005) The intracerebral application of the PPAR\u03b3-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain. Eur J Neurosci 22:278\u2013282","journal-title":"Eur J Neurosci"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-01057-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-022-01057-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-01057-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T04:43:46Z","timestamp":1668660226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-022-01057-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1057"],"URL":"https:\/\/doi.org\/10.1007\/s11011-022-01057-7","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"type":"print","value":"0885-7490"},{"type":"electronic","value":"1573-7365"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"29 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest and declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies were in accordance with the ethical standards of the ethical committee of Kerman University of Medical Sciences (Ethical approval number: IR.KMU.REC.1395.792, Reg. No. 95000573).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest statement"}}]}}